4 completed. 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow coretox: new trials by email Literature Review of coretox trials Research Report on coretox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3) CORETOX®, BOTOX® - Muscle Spasticity | Phase 3 | Completed | Medy-Tox | 220 | 2017-11-13 | 2021-12-07 |
| CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1) CORETOX®, BOTOX® - Muscle Spasticity | Phase 1 | Completed | Medy-Tox | 30 | 2017-07-17 | 2022-01-11 |
| Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line Botox (Botulinum toxin type A), MT10107 (Botulinum toxin type A) - Glabellar Frown Lines | Phase 3 | Completed | Medy-Tox | 136 | 2014-01-01 | 2019-04-10 |
| Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX® MT10107, Botox - Healthy Volunteers | Phase 1 | Completed | Medy-Tox | 25 | 2012-09-01 | 2020-08-26 |
Medy-Tox (4)
South Korea (3)
Huh Changhun, M.D. (1) · Jonghee Lee, M.D. (1) · MyungEun Chung (1) · Yangwon Lee, M.D. (1)